Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
The Diabetes Educator
|
November 1, 1988
CDEs in 1988: a two-year progress report
B J Anderson, R E Ratner, L Warren, et al.
Transplantation
|
June 30, 1998
Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels
T M Sasaki, R S Gray, R E Ratner, et al.
Diabetes, Obesity & Metabolism
|
November 8, 2012
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
R E Ratner, S C L Gough, C Mathieu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 23, 2004
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial
R E Ratner, R Dickey, M Fineman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 14, 2011
Improved health status with insulin degludec compared with insulin glargine in people with type 1 diabetes
P D Home, L Meneghini, U Wendisch, et al.
Journal of Diabetes and Its Complications
|
November 13, 2012
Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults
C A Christophi, H E Resnick, R E Ratner, et al.
Diabetes, Obesity & Metabolism
|
June 17, 2006
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus
R E Ratner, D Maggs, L L Nielsen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
December 31, 2013
A quantitative measure of diabetes risk in community practice impacts clinical decisions: the PREVAIL initiative
B R Shah, M Cox, S E Inzucchi, et al.
Diabetes, Obesity & Metabolism
|
October 15, 2013
Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance
H Florez, M G Temprosa, T J Orchard, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 21, 2012
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study
, T J Orchard, M Temprosa, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
The Diabetes Educator
|
November 1, 1988
CDEs in 1988: a two-year progress report
B J Anderson, R E Ratner, L Warren, et al.
Transplantation
|
June 30, 1998
Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels
T M Sasaki, R S Gray, R E Ratner, et al.
Diabetes, Obesity & Metabolism
|
November 8, 2012
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
R E Ratner, S C L Gough, C Mathieu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 23, 2004
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial
R E Ratner, R Dickey, M Fineman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 14, 2011
Improved health status with insulin degludec compared with insulin glargine in people with type 1 diabetes
P D Home, L Meneghini, U Wendisch, et al.
Journal of Diabetes and Its Complications
|
November 13, 2012
Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults
C A Christophi, H E Resnick, R E Ratner, et al.
Diabetes, Obesity & Metabolism
|
June 17, 2006
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus
R E Ratner, D Maggs, L L Nielsen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
December 31, 2013
A quantitative measure of diabetes risk in community practice impacts clinical decisions: the PREVAIL initiative
B R Shah, M Cox, S E Inzucchi, et al.
Diabetes, Obesity & Metabolism
|
October 15, 2013
Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance
H Florez, M G Temprosa, T J Orchard, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 21, 2012
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study
, T J Orchard, M Temprosa, et al.
Page
of 5